Proteome Sciences plc (LON:PRM – Get Free Report)’s share price fell 15.8% on Wednesday . The company traded as low as GBX 1.60 and last traded at GBX 1.60. Approximately 191,895 shares were traded during mid-day trading, a decline of 53% from the average session volume of 406,055 shares. The stock had previously closed at GBX 1.90.
Proteome Sciences Stock Down 15.8%
The company has a debt-to-equity ratio of -165.46, a quick ratio of 0.37 and a current ratio of 0.13. The stock has a market cap of £5.61 million, a P/E ratio of -1.54 and a beta of 0.15. The company’s fifty day moving average price is GBX 1.64 and its 200-day moving average price is GBX 1.83.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
See Also
- Five stocks we like better than Proteome Sciences
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
- Boxabl Disrupts Housing With A Tiny Float IPO
- Robotaxi Mode Engaged: Tesla Starts Monetizing Its Florida Fleet
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
